Objective-An aneurysm is an inflammatory vascular condition. Phosphatidylinositol 3-kinases δ is highly expressed in leukocytes, and play a key role in innate immunity. However, the link between phosphatidylinositol 3-kinases δ and aneurysm development has not yet been elucidated. Approach and Results-Carotid ligation unexpectedly induced characteristic aneurysm formation beneath the ligation point in p110δ D910A/D910A mice (n=25; P<0.001 versus wild-type). Besides, p110δ inactivation exacerbated CaCl 2induced abdominal aortic aneurysms development. A reverse transcription polymerase chain reaction microarray revealed significant extracellular matrix components degradation and matrix metalloproteinases (MMPs) upregulation in the abdominal aorta of p110δ D910A/D910A mice. Similarly, the expression of both collagen I and IV was significantly decreased (n=10; P<0.05 versus wild-type) in carotid artery. Western blot assay confirmed that MMP-12 was significantly upregulated in arteries of p110δ D910A/D910A mice (n=10; P<0.01 versus wild-type). In vitro, p110δ inactivation marked increase peritoneal macrophages recruitment and synergistically enhance tumor necrosis factor-α-induced recruitment. A specific phosphatidylinositol 3-kinases δ inhibitor (IC87114) or genetic p110δ inactivation upregulated MMP-12 expression and c-Jun phosphorylation (n=6; P<0.05 versus wild-type macrophages). IC87114 also increased activator protein-1 DNA-binding activity (n=6; P<0.001 versus control) and enhanced the effect of tumor necrosis factor-α on activator protein-1-binding activity (n=5; P<0.01 versus tumor necrosis factor-α treatment groups). Knockdown of c-Jun suppressed the effect of the IC87114 and tumor necrosis factor-α on MMP-12 mRNA expression (n=5 in each group; P<0.01 versus scrRNA treatment groups).
A neurysms frequently lead to high morbidity and mortality as a result of rupture or dissection without symptoms. 1 Aortic aneurysms, including abdominal aortic aneurysm (AAA), thoracic aneurysms, and carotid aneurysms, are highly common conditions, with AAA being 3 times more prevalent than thoracic aneurysm. 2 Although they are typically regarded as being distinct entities, vascular inflammation is a common pathogenic factor in them. 3, 4 Pathological features of aneurismal diseases include transmural inflammatory cell infiltration, noticeable breakdown of elastic lamellae, smooth muscle cell loss, endothelial cell death and detachment, neovascularization, calcium deposition, and focal aneurysmal dilation of the vessel wall. 5, 6 However, the specific cellular mechanisms that underlie aneurysm formation and progression are poorly understood.
Increasing evidence 7, 8 points to an important role for innate immune cells in the pathobiology of aneurysms. Monocytes/ macrophages infiltrate the vessel wall and release proteases, including elastase (matrix metalloproteinase-12 ) and metalloproteinases that compromise the integrity of the vascular wall through degradation of the extracellular matrix (ECM). Monocytes/macrophages also secrete inflammatory cytokines in the media and adventitia of aneurysmatic vessels, such as tumor necrosis factor (TNF)-α, interferon-γ, interleukin-1β, [9] [10] [11] and interleukin-6, 12 which are reported significantly increased in patients with AAA. As a central role in AAA, macrophages may be classically activated by tolllike receptor (TLR) ligands. Studies recently have confirmed that deficiency of TLR4 or its adaptor protein MyD88 reduced angiotensin II-induced AAA formation. 13 Meanwhile, TLR signaling pathway has cross-talk with phosphatidylinositol 3-kinase (PI3K) during innate immune. Accumulating evidence has established the role of PI3K in the attenuation of TLR signaling. [14] [15] [16] [17] PI3Ks are a family of ubiquitously expressed enzymes that possess both lipid and protein kinase activities. Indeed, PI3K has been reported to be involved in a variety of cellular functions, including cell growth, survival, and migration. 18 PI3Ks can be grouped into 3 different classes. Class I PI3Ks are heterodimeric enzymes, consisting of a p55, p85, or p101 regulatory subunit and a p110 catalytic subunit (classified as α, β, γ, and δ, respectively). 19, 20 The p110 catalytic subunit catalyzes the generation of phosphatidylinositol 3,4,5 trisphosphate (PIP3) and activates numerous downstream targets, 21 including the serine-threonine kinase protein kinase B/Akt, which is involved in antiapoptosis, proliferation, and oncogenesis. PI3Kδ is a Class I family member and is low or absent in most cells but is predominantly expressed in leukocytes. 22 The role of PI3Kδ in leukocytes has been confirmed in PI3Kδ D910A kinase-dead knock-in mice (PI3K p110δ D910A/D910A ). 23 These PI3Kδ-inactivated mice showed defects in B-and T-cell signaling 24 and impaired humoral immune responses. In p110δ D910A/ D910A mice, macrophages are hyperresponsive to TLR singaling and the augmented TLR signaling pathways elicits an exuberant inflammatory response. 25 Besides, the direct inhibition of Akt in monocytes resulted in a proinflammtory phenotype similar to that observed with PI3K inhibition. 26 Therefore, we hypothesized that inactivation of PI3Kδ/Akt signaling in macrophages play a crucial role in AAA development.
To test this hypothesis, we investigated the effect of PI3Kδ inactivation on artery architecture and AAA development in 2 distinct murine models in p110δ D910A/D910A mice and in vitro experiments with macrophage migration and MMPs expression. Our results suggested that MMP-12 is the most important molecules influenced by p110δ inactivation in arteries and in vascular injury models. Furthermore, PI3Kδ inactivation promotes macrophages recruitment and upregulates MMP-12 expression via mediating activator protein (AP)-1 protein activation in macrophages.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Inactivation of PI(3)K p110δ Unexpectedly Induced Aortic Aneurysm Formation In Carotid Injury Model
In carotid injury model, hematoxylin-eosin staining ( Figure 1A , a1 and a2, c1 and c2) revealed that carotid ligation results in similarly significant neointima formation and neointima/media area ratios (data not shown) of injured carotid arteries were marked reduced in wild-type (WT) as well as in p110δ D910A/D910A mice but the arrows in Elastica van Gieson staining images showed that wavy elastic fiber and fragments seemed only in p110δ D910A/D910A mice not in WT mice. Beneath the ligation point, serial sections further showed that a remarkable loss of medial smooth muscle cells, the separation of the layers within the aortic wall, significant fragmentation of elastic lamellae, and significant matrix degradation under the adventitia of the carotid artery colocalized with massive inflammatory cells in p110δ D910A/D910A mice ( Figure 1A , c3-c6). Furthermore, immunohistochemical staining showed that a large number of CD68-positive macrophages infiltrated under the adventitia ( Figure I in the onlineonly Data Supplement). In contrast, the carotid arteries of WT mice with surgery showed foci of reduced vascular smooth muscle cells (VSMCs) and loosen media. However, no apparent inflammation was observed in the media of WT mice after surgery ( Figure 1A , a3-a6; Figure I in the online-only Data Supplement). Besides, 4 weeks after ligation surgery, 27% of p110δ D910A/D910A mice (n=25) unexpectedly exhibited characteristic aneurysms beneath the ligation point of the common carotid, whereas this did not occur in WT mice (n=25; P<0.001; Figure 1B ). The maximal external and internal diameters of carotid arteries of p110δ D910A mice was significantly larger than that of WT mice (n=25; P<0.05; Figure 1C ).
Inactivation of PI(3)K p110δ Exacerbates CaCl 2 -Induced AAA Development
To further determine the role of p110δ inactivation in aneurysm development, we examined the pathology of CaCl 2 -induced AAA model in WT and p110δ D910A/D910A mice. Morphometric analyses of the abdominal aortae showed although CaCl 2 induced AAA pathology in WT and p110δ D910A/D910A mice, significant dilation of the external and internal aortic diameters in the p110δ D910A/D910A mice compared with WT or IC87114treatment WT mice (Figure 2A-2C ). Besides, the dilation of aorta was accompanied by thinning of the medial layer, calcium deposition, and massive disruption of the elastic lamellae, which showed limited dilation and foci of disruption of the elastic lamellae instead of extensive damage in WT mice. Similarly, IC87114, specific p110δ inhibitor, significantly promotes inflammatory cells recruitment under the adventia and result in the thinner medial layer and larger aortic diameters after treatment for 4 weeks in comparison with CaCl 2induced WT mice, suggesting p110δ inactivation probably alter inflammatory cells function to induce vascular injury Figure 2D ).
Inactivation of PI(3)K p110δ Dysregulated the Expression Profiles of ECMs and Metalloproteinases in the Aorta
Considering PI3Kδ D910A/D910A mice are susceptive to inflammatory irritant, we doubted that PI3Kδ inactivity might have an effect on normal vessel structure. Therefore, we examined the ultrastructure of the carotid artery from both types of mice using perfusion fixation at constant pressure ≈100 mm Hg as we previously reported. 27 In p110δ D910A/D910A mice, electron microscopy showed significant migration and disarray of smooth muscle cells in the vessel wall, thinning of the wavy elastic lamellae and deposition of the amorphous matrix between VSMCs ( Figure II in the online-only Data Supplement). Hematoxylin-eosin staining shows that the diameter of carotid arteries has no difference between both types of mice after perfusion fixation. In addition, immunohistochemical analyses showed collagen I and IV expressions in carotid artery remarkably reduced in p110δ D910A/D910A mice compared with WT mice (Figure 3 , a1-a3). In abdominal aorta, immunofluorescence and western blot assays revealed that the expression of α-smooth muscle actin was lower than that of WT mice (Figure 3 , b1). Moreover, reverse transcription polymerase chain reaction microarray assays for ECM and adhesion molecules using the abdominal aortic arteries from both types of mice showed that the genes expression of crucial ECM components, such as Col1a1, Col2a1, Col3a1, Col4a3, Fibronectin l, and Laminin γ1 were significantly downregulated, whereas ECM degradative enzymes, including MMP-12, MMP-3, MMP-9, and MMP-11 were upregulated (Figure 3, b2 ). In particular, western blot assay confirmed that the expression of MMP-12 was significantly higher than that of WT mice (n=10; P<0.01; P<0.05; Figure 3 , b3). These data suggested that p110δ inactivation contribute to vascular injury probably because of dysregulating ECM/ MMPs expression in vessels.
p110δ Inactivation Upregulates MMP-12 Activity and Expression in CaCl 2 -Induced AAA Mice
Previous studies have reported that MMP-12 play a key role in the CaCl 2 -induced AAA model 28 and MMP-12 expression in patients with AAA significantly enhanced. 29 Moreover, our results also revealed the link between p110δ inactivation and MMP-12 upregulation. Next, we further analyzed the MMP-12 activity in serum from AAA mice. Casein zymography showed that CaCl 2 significantly increased MMP-12 activation compared with sham-operated mice but the activity of MMP-12 was higher in p110δ D910A/D910A mice than WT-AAA mice. IC87114 also enhance MMP-12 activity in WT-AAA mice ( Figure 4A, a1 ). Notably, in AAA foci, MMP-12 expression was significantly increased under adventitia in each group compared with MMP-9 or MMP-2 expression ( Figure III in the online-only Data Supplement). We then examined the cellular distribution of MMP-12 in aneurismal sections by confocal microscopy. We found that the cellular localization of MMP-12 (red) from aneurismal segments in macrophages (CD68, in green; Figure 4 , b1) and to a lesser extent, in VSMCs (green; Figure 4 , b3). Furthermore, our results demonstrate p110δ (red) specifically colocalized with vascular macrophages (CD68, in green; Figure 4 , b2). Therefore, these results suggested that PI3Kδ inactivation may induce macrophages infiltration and activate MMP-12 expression in macrophages.
Inactivation of PI(3)K p110δ Promotes Macrophages Migration, MMP-12 Expression, and AP-1 Phosphorylation
Because macrophages are important innate inflammatory cells in AAA development and TNF-α is thought to be involved in the pathogenesis of AAA. 12 We next wondered whether p110δ inactivation enhanced macrophage recruitment. We cultured macrophages by use of a transwell system. p110δ inactivation significantly enhances macrophages recruitment compared with WT macrophages ( Figure 5 , a1 and a2; *P<0.05, **P<0.01, ***P<0.001 versus control-WT macrophages). TNF-α induce more p110δ D910A/D910A macrophages recruitment than did the WT macrophages ( Figure 5 , a3 and a4; #P<0.05, ##P<0.01 versus control-p110δ D910A/D910A macrophages). Besides, IC87114-treatment significantly enhance WT macrophages recruitment induced by TNF-α compared with dimethyl sulfoxide-treatment WT macrophages but IC87114treatment has no effect on p110δ D910A/D910A macrophages recruitment induced by TNF-α ( Figure 5 , a5 and a6; ΔP<0.05 versus TNF-α-treated WT macrophages), which agrees with the in vivo observation that p110δ inhibition or p110δ inactivation induced inflammatory cell infiltration in the adventitia and disruption of elastic lamella in CaCl 2 -induced mice. In addition, we then examined the MMP-12 expression in both types of peritoneal macrophages. Our results showed that in p110δ D910A/D910A macrophages, Akt phosphorylation was significantly suppressed compared with WT macrophages (n=3; P<0.01 versus WT macrophages; Figure 5B ). TNF-α treatment effectively inhibited Akt activation in both types of mice. Meanwhile, TNF-α induced remarkable increased MMP-12 expression in p110δ D910A/D910A macrophages compared with WT macrophages (n=3; P<0.01 versus WT macrophages).
Considering that TNF-α, which is known to increase the transcriptional level of MMP-12 and to enhance the mRNA stability of MMP-12, controls MMP-12 expression via AP-1 (c-Jun/c-Fos) activation, 30 we further examined the effect of p110δ inactivation on c-Jun expression and activation. Notably, p110δ inactivation significantly induced c-Jun expression and phosphorylation compared with WT macrophages, and this was greatly enhanced by TNF-α treatment. Therefore, our results demonstrated that p110δ inactivation altered macrophages recruitment, upregulated MMP-12 expression, and enhanced the effect of TNF-α on macrophages.
p110δ Inhibition Upregulated MMP-12 Expression by Activating AP-1 in Macrophages
To further investigate the molecular mechanisms of whether p110δ inactivation regulate MMP-12 expression mediated by AP-1 activation, we use mouse macrophage (RAW 264.7) cells, which have features similar to macrophages and express elastolytic proteases such as MMP-12 31 in vitro experiment. We also used IC87114 (10 μmol/L) 32 to selectively inhibit PI3Kδ catalytic activity to address this question. Our data showed that IC87114 (10 μmol/L) effectively inactivated Akt in macrophages after treatment for 1 hour (n=6; P<0.001 versus control; Figure 6A ). We next detected the effect of IC87114 on AP-1 DNA-binding activity. The electrophoretic mobility shift assay assay demonstrated that DNA-binding activity of AP-1 was significantly increased after the treatment with TNF-α (10 ng/mL; P<0.001) and TNF-α (20 ng/ mL; P<0.001). IC87114 alone marked induced AP-1 DNAbinding activity after treatment for 1 hour. Furthermore, our results demonstrated that there was stronger AP-1 DNAbinding activity after costimulation of IC87114 (10 μmol/L) and TNF-α (0-20 ng/mL) than only treatment with TNF-α (0-20 ng/mL; n=5; P<0.01; Figure 6B ). Meanwhile, phosphorylated-c-Jun (p-c-Jun) antibody caused a characteristic supershift of the retarded complex. These data suggested that Figure 6C; n=6 ; P<0.05 for TNF-α treatment; P<0.001 for IC87114 treatment). Then, western blotting demonstrated that the expression of p-c-Jun was higher after cotreatment with IC87114 (10 μmol/L) and TNFα (10 ng/mL) than stimulation with just one of them (n=6; P<0.001). Reverse transcription polymerase chain reaction analysis showed that MMP-12 mRNA was also significantly enhanced by cotreatment with IC87114 (10 μmol/L) and TNF-α (10 ng/mL; n=6; P<0.05; Figure 6C ). IC87114 (10 P<0.05) . These results demonstrated that p110δ inactivation indeed upregulate MMP-12 mRNA expression by strengthening AP-1 DNA-binding activity and activation of c-Jun in macrophages. Inmunofluorescence analysis also showed that macrophages specifically colocalized with p-cjun in AAA arteries ( Figure 6E ).
Discussion
In this study, we demonstrated that in vivo p110δ inactivation induced significantly aneurismal pathology and macrophages recruitment in 2 distinct models and exacerbated CaCl 2 -induced AAA development via dysregulation of MMP-12 expression. Besides, MMP-12 mainly colocalized with CD68-positive macrophages in aneurismal segment. In vitro experiment, we demonstrated that p110δ inactivation facilitates macrophages migration and pharmacological specific inhibitor of p110δ also has similar effect on WT macrophages. Moreover, p110δ inactivation or inhibitor marked induced MMP-12 upregulation via phosphorylation of AP-1. Besides, p110δ inactivation enhances the effect TNF-α/TNFR on MMP-12 expression mediated by activation of AP-1 protein (Figure 7 ). Like atherosclerosis, aneurysms are a progressive inflammatory vascular condition. Depletion of macrophages 8 or preventing them from expressing ECM degrading enzymes such as MMPs protected mice from developing aneurysm. 33, 34 The most prominent feature is irreversible degeneration of the elastic media induced by inflammatory response. 35 Carotid ligation model can induce vascular inflammation and neointima lesion formation. 36 Here, we use this model to investigate the effect of leukocytes-specific p110δ on vascular remodeling. Interestingly, p110δ D910A/D910A mice showed 2 distinct pathologies including significant neointima formation, luminal stenosis and unexpectedly typical arterial aneurysm formation beneath the carotid ligation point. Notably, both the pathologies display elastic fiber fragments. Serial sections with immunohistochemical staining discovered massive CD68-positive macrophages recruitment under adventitia and hematoxylin-eosin staining showed remarkable dilation in aneurismal section suggesting that p110δ inactivation may promotes macrophage infiltration induced by carotid ligation and consequently causes characteristic aneurysm formation. However, the incidence of aneurysm in p110δ D910A/D910A mice was only 27%, which suggested that multiple PI3K/Akt functions in various vessel cells or other PI3K classes probably involve in protection against inflammatory injury. By contrast, WT mice only showed similar neointima formation and stenosis but without elastic fiber fragments and aneurismal pathology. Furthermore, in CaCl 2 -induced AAA model, p110δ D910A/D910A mice present markedly reduced VSMCs in media, inflammatory cells infiltration, massive calcium deposition under adventitia, and loosened adventitia compared with WT mice, suggesting that p110δ inactivation actually exacerbates vascular inflammatory response and result in abnormal pathology. Similarly, treatment with IC87114 for 4 weeks leads to marked inflammatory cells recruitments, destruction in media, and focal calcium deposition in CaCl 2 -induced WT AAA mice. Besides, in sham-operated groups, p110δ D910A/D910A mice also showed abnormal ultrostructure in carotid arteries including wavy elastic fiber and VSMC derangement compared with WT mice. Subsequently, reverse transcription polymerase chain reaction microarray assay from abdominal aorta tissues showed p110δ inactivation significantly induced MMP-12 mRNA expression in comparison with WT sham-operated mice. Western blot analysis further demonstrated marked reduced Akt phosphorylation and enhanced MMP-12 expression in abdominal aorta and carotid artery in p110δ D910A/D910A mice. Casein zymography further demonstrated that p110δ inactivation results in elevated MMP-12 activity in serum, and they are significantly higher in p110δ D910A/D910A mice than that of in WT mice after CaCl 2 challenged. Moreover, MMP-12 expression in each group was higher than MMP-9 or MMP-2 expression in AAA foci. Therefore, the effect of p110δ inactivation on inflammatory cells recruitment and MMP-12 dysregulation in arteries probably contribute to abnormal carotid artery architecture and aortic aneurysm development.
Actually, inflammatory process involving MMP activities is essential for the vascular remodeling, entailing reorganization of the ECM scaffold of the vascular wall, and particularly mediating atherosclerotic plaque progression 37 and AAA. 38 Meanwhile, MMP-12 deficiency attenuated CaCl 2 -induced AAA probably via decreasing macrophage recruitment. 28 Furthermore, it is known that macrophages are an important source of MMP-12, which is required for macrophage-mediated proteolysis and matrix invasion in vitro. 39 In line with these studies, our results showed that significantly increased MMP-12 expression was mainly localized in CD68-positive macrophages of aneurysmal segments in CaCl 2 -induced WT mice, indicating that p110δ inactivation mediated vascular pathology probably via regulating MMP-12 expression in macrophages.
As mentioned, p110δ and p110δ isoforms of PI3-kinase are highly expressed in leukocytes such as macrophages, B and T cells. PI3Ks have emerged as important regulators of TLR signaling. 40 The ability of TLRs to facilitate the activation of and induction of immunomodulatory cytokines from antigen-presenting cells, such as dendritic cells or macrophages is critical in shaping the adaptive immuneresponse. 41 However, depending on the circumstances, PI3K can function either as a positive or negative regulator of TLR signaling. 42 Indeed, PI3K activation enhances the immune response in mast cells and potential other granulocytes, but clearly dampens the inflammatory response in monocytes, macrophages, and dendritic cells. 43 TLRs and the receptor for tumor necrosis factor (TNF-R) play an important role in innate immunity by regulating the activity of distinct transcription factors, such as nuclear factor-κB and AP-1 (cFos/cJun). 44 TNF-α can bind to its receptor (TNF-R) and elicit diverse biological responses involved in AAA including activation and recruitment of immune cells to the sites of inflammation, the secretion of proinflammatory cytokines, and MMPs. 11 In AAA tissue, TNF-α expression colocalizes mainly with CD68-positive macrophages in the medium and adventitia. 45 Besides, MMP-12 expression (mRNA and protein) is controlled by AP-1 activation after TNF-α treatment in monocytes. 31 Therefore, in vitro experiment, we used TNF-α as a stimulus to define the mechanism of p110δ inactivation on macrophage migration and MMP-12 expression. Besides, p110-specific inhibitor IC87114 was validated investigating neutrophil priming or B-cell responses in drug-treated cells versus cells isolated from mice harboring kinase-dead p110δ. 24, 46 Our results showed that genetic inactivation of p110δ or pharmacological inhibitor IC87114 has similar effect on significantly increasing macrophages migration. Other studies 25 has showed that PI3K signaling is significantly diminished in PI3K p110δ D910A/D910A bone marrow monocytes (BMMs) as demonstrated by decreased phosphorylation of the PI3K downstream target Akt in LPS-activated PI3K p110δ D910A/D910A BMMs compared with WT BMMs. In addition, LPS-activated p110δ D910A/D910A BMMs displayed that earlier activation and enhanced phosphorylation p38 mitogenactivated protein kinase but there were no significant differences in extracellular-signal-regulated kinases activation and nuclear factor-κB p65 phosphorylation in comparison with WT BMMs. Our results showed that TNF-α treatment induced marked enhanced MMP-12 expression and c-Jun phosphorylation in p110δ D910A/D910A macrophages compared with WT macrophages, whereas Akt phosphorylation was significantly reduced in both types of macrophages, which indicate Akt inactivation probably involving in AAA development and negatively regulating AP-1 activation. Moreover, IC87114 significantly increased AP-1 DNA-binding activity in RAW cells and synergistically increased AP-1-binding activity with TNF-α. Subsequently, the effect of IC87114 on MMP-12 upregulation after TNF-α treatment was significantly suppressed by c-Jun knockdown. Meanwhile, we also demonstrated that p-c-Jun was specifically colocalized within nucleus of macrophage in aneurismal sections. Therefore, we demonstrate that p110δ inactivation increased MMP-12 expression at mRNA level and protein level in macrophages by inducing AP-1 activation, which probably results from c-Jun kinase activation. Likewise, studies have demonstrated that AKT2 deficiency 47 and c-Jun N-terminal kinase activation 38 aggregated AAA development, whereas c-Jun is the major target of c-Jun N-terminal kinase pathway. Besides, nuclear factor-κB also has been reported to regulate MMPs and promote the development of experimental AAA 48 via AP-1 activation. p110δ inactivation may mediate these pathways during vascular injury.
Taken together, a genetic defect in specific intracellular signaling molecule contributes to global defects in adaptive homeostatic pathways in the intestine 25 and in vessels. Pathogenesis of AAA was closely associated with innate immune disorder. However, PI3Ks have complicated crosstalk with TLRs and TNF-R pathways ultimately mediated inflammatory transcription factors, such as nuclear factor-κB and AP-1 activation, which may results in inflammatory cytokines release and MMPs expression. Elucidation of the details of PI3Kδ-related molecular events may identify further potential therapeutic targets for inflammatory vascular diseases with destructive ECM metabolism.
